Virtus Investment Advisers’s Boston Scientific BSX Stock Holding History

Virtus Investment Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,891	Closed	-$1.8M	–	458
2025 Q4	$1.8M	Buy	18,891 +1,582	+9%	+$155K	0.49%	83
2025 Q3	$1.69M	Buy	17,309 +3,709	+27%	+$384K	0.48%	108
2025 Q2	$1.46M	Sell	13,600 -285	-2%	-$28.8K	0.49%	88
2025 Q1	$1.4M	Buy	13,885 +12,425	+851%	+$1.25M	0.38%	57
2024 Q4	$130K	Buy	+1,460	New	+$129K	0.1%	234
2018 Q1	–	Sell	-26,521	Closed	-$657K	–	71
2017 Q4	$657K	Sell	26,521 -2,474	-9%	-$68.2K	0.07%	260
2017 Q3	$846K	Sell	28,995 -2,625	-8%	-$72.5K	0.09%	244
2017 Q2	$877K	Sell	31,620 -6,218	-16%	-$165K	0.09%	241
2017 Q1	$941K	Sell	37,838 -3,676	-9%	-$89.4K	0.08%	248
2016 Q4	$898K	Sell	41,514 -39,970	-49%	-$872K	0.07%	286
2016 Q3	$1.94M	Buy	+81,484	New	+$1.94M	0.12%	225

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Virtus Investment Advisers's BSX Position: Q1 2026 in Review

Virtus Investment Advisers sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 18,891 shares — an estimated $1.8M sold.

Virtus Investment Advisers first reported a position in BSX in Q3 2016 and held it in 11 quarters. The position peaked at $1.94M in Q3 2016. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Virtus Investment Advisers reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Virtus Investment Advisers sold 18,891 Boston Scientific shares in Q1 2026, an estimated $1.8M.
Virtus Investment Advisers first reported a position in Boston Scientific in Q3 2016 and held it in 11 quarters.
Virtus Investment Advisers's Boston Scientific position peaked at $1.94M in Q3 2016.
1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.